REMOVAL OF CYTOKINE INDUCING SUBSTANCES BY POLYMYXIN-B IMMOBILIZED POLYSTYRENE-DERIVATIVE FIBERS DURING IN-VITRO HEMOPERFUSION OF 10-PERCENT HUMAN PLASMA CONTAINING STAPHYLOCOCCUS-AUREUS CHALLENGE

Citation
Bl. Jaber et al., REMOVAL OF CYTOKINE INDUCING SUBSTANCES BY POLYMYXIN-B IMMOBILIZED POLYSTYRENE-DERIVATIVE FIBERS DURING IN-VITRO HEMOPERFUSION OF 10-PERCENT HUMAN PLASMA CONTAINING STAPHYLOCOCCUS-AUREUS CHALLENGE, ASAIO journal, 44(1), 1998, pp. 48-53
Citations number
28
Categorie Soggetti
Engineering, Biomedical
Journal title
ISSN journal
10582916
Volume
44
Issue
1
Year of publication
1998
Pages
48 - 53
Database
ISI
SICI code
1058-2916(1998)44:1<48:ROCISB>2.0.ZU;2-A
Abstract
Staphylococcus aureus (S. aureus) is frequently isolated from blood cu ltures in the hospital setting. The pathogenesis of S. aureus bacterem ia probably replicates mechanisms implicated in gram negative bacteria l infections. Cell wall components, such as peptidoglycans and lipotei choic acids (LTA), can trigger cytokine production. Polymyxin-B (PMX-B ) is a cationic peptide that binds endotoxin (ET) and inhibits its act ivity. Based on this principle, PMX-B was incorporated in polystyrene- derivative fibers, creating a hemoperfusion column (PMX-20R) that remo ves ET. The authors assessed whether S. aureus possesses PMX-B suppres sible cytokine-inducing substances, and whether LTA, an anionic molecu le, is one such substance. Heparinized blood was obtained from healthy volunteers, peripheral blood mononuclear cells (PBMC) were isolated b y Ficoll-Hypaque separation, and 10% human plasma prepared. PBMC were incubated with 1, 5, or 10 mu g/ml of S. aureus LTA, with and without 10 mu g/ml of PMX-B. Also, using PMX-20R, in vitro hemoperfusion (IVH) was performed with 10% human plasma containing 1:1,000 dilution of S. aureus challenge at 100 ml/min for 2 hours at 37 degrees C, and plasm a obtained before and after IVH was incubated with PBMC. After a 24 ho ur incubation at 37 degrees C, PBMC were subjected to three freeze-tha w cycles, and total TNF alpha was measured by radioimmunoassay. TNF al pha production by PBMC incubated with LTA was 164 +/- 4 pg, 324 +/- 54 pg, 657 +/- 55 pg, and 1143 +/- 215 pg in control, and LTA 1, 5, and 10 mu g/ml, respectively. The addition of PMX-B resulted in a 40 +/- 1 2% (p = 0.02), 61 +/- 6% (p = 0.002), and 62 +/- 14% (p = 0.02) decrea se in TNF alpha production, respectively. Before IVH, TNF alpha produc tion by PBMC incubated with 10% plasma containing S. aureus challenge was 1275 +/- 70 pg. After 2 hours of IVH, the decrease in TNF alpha pr oduction was 20 +/- 4% (p = 0.002). In conclusion, S. aureus LTA induc es TNF alpha production that is significantly suppressed by PMX-B. Con sequently, S. aureus cytokine-inducing substances are removed during I VH with PMX-20R, and this may be due to stoichiometric binding of LTA to PMX-B.